Funding
We have listed below some of the key funding calls (mainly grants) that are applicable to companies in UK healthcare. For more information, please contact us.
Past funding calls can be viewed using these links:
Upcoming Funding Calls
Current Funding Calls
​Research and partnership hubs for a healthy society
Funder: Engineering and Physical Sciences Research Council
Opened: 15 July 2025
Closes: 4pm, 21 October 2025
Sector: Healthcare & Life Sciences
Apply for funding to establish a large-scale multidisciplinary research hub drawing on expertise across the Engineering and Physical Sciences Research Council (EPSRC) and health research community to support people to live healthier lives and prevent ill health. Proposals should address long term research challenges in the priority area(s) of prevention, early diagnosis and self-management of health.
You must be based at a UK research organisation eligible for EPSRC funding. This funding opportunity will have a two-stage assessment process consisting of an outline stage and a full proposal stage The full proposal stage will be assessed through expert peer review and interview.
​
Hub challenge areas
The hubs that are funded through this funding opportunity will be critical mass investments that are expected to form connections to the wider health technologies research and innovation ecosystem. They will have a core mission and sets of activities and objectives in one or more of the following areas:
-
Prevention and population health
This priority looks to focus on the need for novel techniques that optimise health, prevent, and ultimately help eliminate disease. -
Supporting people to manage their own health
This priority focuses on a shift in services out of hospitals and into the community and home. -
Novel techniques for early diagnosis
Hubs addressing this priority area are expected to develop novel techniques that optimise patient-specific illness prediction and early and accurate diagnosis.
More information here.
EIC Pathfinder
Funder: European Commission - Horizon
Opened: 21 May 2025
Closes: 29 October 2025
Sector: ALL
There are two types of Pathfinder grants:
-
‘EIC Pathfinder Open’ open to support projects in any field of science, technology or application without predefined thematic priorities. The overall budget for the EIC Pathfinder Open in 2025 is €142 million.
-
‘EIC Pathfinder Challenges’ to support coherent portfolios of projects within predefined thematic areas with the aim to achieve specific objectives for each Challenge. The overall budget for the EIC Pathfinder Challenges in 2025 is €120 million.
Open Call: Grants up to EUR 3 million
Challenge Call: Grants up to EUR 4 million.
Higher amounts if duly justified. Projects to achieve the proof of principle and validate the scientific basis of breakthrough technologies (starting from early TRLs aiming at achieving TRL3 or 4).
Who can apply
Consortia from EU Member States and countries associated to the Horizon Europe programme:
-
Consortia of at least three different independent legal entities
-
At least one legal entity established in a Member State
-
At least two other independent legal entities, each established in different Member States or Associated Countries
-
Additionally, single applicants, small and larger consortia (two partners) for EIC Pathfinder Challenges only.
Your proposal must meet all the following essential characteristics:
-
Ambitions long-term vision for a radically new technology that has the potential to create new market and provide solutions for global challenges
-
High-risk/high-gain breakthrough research that provides the foundations of the technology that you envisioning
EIC Work Programme 2025 - here
More information here.
Generative-AI based Agents to Revolutionise Medical Diagnosis and Treatment of Cancer
Funder: Horizon EIC
Opened: 28 July 2025
Closes: 29 October 2025
Sector: Healthcare & Life Sciences
Aim: To create interactive GenAI autonomous agents and/or a combination of them that provide clinicians with a holistic end to end perspective of patient care.
​
Grants of up to 3 to 4 million euros to support early stage development of future technologies (e.g. various activities at low TRL 1-3), up to proof of concept.
​
Project proposals under this Challenge should focus on one (and only one) of the following diseases: breast cancer, cervical cancer, ovarian cancer, prostate cancer, lung cancer, brain cancer, stomach cancer or colorectal cancer.
Each proposal should address both the following areas (at least one sub-objective from each of the areas):
​
Area 1: Technological areas
-
GenAI-based tools for Integrating Multidimensional Multimodal health Data
-
Medical Data Augmentation
-
Medical Knowledge Representation and Integration
​
Area 2: Clinical Areas​
-
Predictive Diagnosis
-
Enhance Personalised Treatment Selection
​
Projects should also conduct proof of concept studies in controlled settings to demonstrate improved and more accurate diagnosis and treatment when compared to current clinical practice. The viability of the developed technologies should be evaluated, guiding further refinement and improvement. For instance, a super-agent could be validated for assisting and/or replacing clinicians through the whole clinical pathway of the patient, providing a holistic view of patient care, that is currently unachievable due to fragmented healthcare systems and associated expertise.
​
The focus should also be on enhancing the interpretability of AI models/agents, making their decision-making processes more transparent and understandable to clinicians. This could involve developing cutting-edge techniques such as causal inference methods, explainable AI frameworks, or novel visualisation tools that provide deeper insights into AI decision-making processes.
​
The AI models developed under this Challenge are expected to comply with the EU concept for Trustworthy AI, relevant ethical principles, and the AI Act. In addition to focusing on performance, careful attention must be given to data quality, transparency, privacy, and security.
More information here and here.
​
Biomedical Catalyst Accelerator – Hospital to Community
Funder: Innovate UK
Opened: 10 September 2025
Closes: 12pm, 31 October 2025
Sector: Healthcare
​Supporting up to 10 early stage startups working on remote monitoring, at-home diagnostics, new community care models, and digital tools that ease hospital pressure. Provides investment-readiness support, expert-led workshops, tailored one-to-one mentoring, and access to healthcare leaders, VCs, healthtech ecosystem and alumni network.
​
Founders gain investment-readiness support, expert-led workshops, tailored one-to-one mentoring, and access to healthcare leaders, VCs, and our healthtech ecosystem and alumni network. Designed and delivered by Founders Factory with Innovate UK, part of UKRI, the accelerator helps build earlier, local, and preventative care that delivers better outcomes for patients.
More information here.
Expressions of interest: artificial intelligence humanities sandpits: Canada, UK and US
Funders: AHRC, EPSRC and SSHRC (Canada)
Opened: 1 September 2025
Closes: 4pm, 31 October 2025
Sector: ALL
This is a highly specialised, international, and intensive funding opportunity. It is not a standard research grant for a pre-defined project. It is best suited for collaborative, risk-taking academics and creatives from the humanities and tech sectors who want to co-create entirely new ideas around AI in a workshop setting.
​
Core Concept: An intensive 5-day workshop (a "sandpit") in Canada (Feb 2026) for UK, US, and Canadian researchers to collaboratively design new projects on AI's impact on human knowledge ("Knowing") and identity ("Being").
​
The Funders are looking for 60 participants from UK, Canadian and US research organisations to take part in in-person and virtual workshops. During the sandpit process, teams will form, develop and refine project ideas through a facilitated process guided by the sandpit Director and Mentors. They plan to fund up to four grants. £625,000 is available for UK-based team members, of which AHRC will pay 80%.
​
This sandpit is jointly delivered by the UK’s AHRC through the International Science Partnerships Fund (ISPF), and SSHRC in partnership with the Alan Turing Institute and The University of Edinburgh.
​
-
Who: Humanities scholars, AI/tech researchers, and creative practitioners. Must be based in the UK, US, or Canada.
-
Format: No pre-defined projects. You co-create ideas from scratch at the workshop.
-
Funding: Travel and accommodation for the sandpit is covered. The best ideas developed there will receive follow-on funding (e.g., up to £100k for UK applicants). There will be four grants awarded.
More information here.
STEP Scale Up
Funder: European Innovation Council
Open
Closes: 31 October 2025
Sector: ALL
​The EIC STEP Scale Up scheme is part of the Strategic Technologies for Europe Platform (STEP), offering financial support in the form of investments to startups, SMEs, and small mid-caps, between EUR 10 to 30 million.
Its goal is to scale-up innovation in Europe’s strategic technology sectors, particularly in quantum technologies and semiconductors, thereby enhancing the EU´s economic and technological competitiveness. The EIC Step Up scheme will catalyse larger funding rounds, amplifying the impact of the initial investment.
Who can apply?
-
A single SME or small mid-cap (up to 499 employees) established within a Member State or an Associated Country.
-
An investor may submit a proposal on behalf of an eligible SME or small mid-cap as defined above,
Note: This scheme targets companies seeking major funding rounds, requiring proof of initial market interest from a qualified investor covering at least 20% of the total target funding round.
​
Scope of innovation
-
Digital and Deep Tech: Includes semiconductor, AI, quantum, advanced connectivity, sensing, robotics, and autonomous systems.
-
Clean Technologies: Focus on net-zero solutions like solar, wind, battery storage, geothermal, hydrogen, biogas, carbon capture, nuclear, and circular economy.
-
Biotechnologies: Includes critical medicines, DNA/RNA, proteins, cell engineering, gene vectors, bioinformatics, and nanobiotechnology.
Grant funding
Budget
-
Total 2025 budget of EUR 300 million.
-
Minimum investment EUR 10 million, maximum EUR 30 million in 2025.
Equity only investments
Managed by the EIC Fund, the STEP Scale Up scheme aims to bridge the funding gap for high-risk innovations that cannot be fully financed by other investors.
More information here.
​Translation Accelerator Kidney Awards
Funder: Kidney Research UK
Opened: 1 October 2025
Closes: 31 October 2025
Sector: Healthcare
The aim of the Translation Accelerator Kidney Award Scheme (TAKA) is to fund projects that accelerate the translation of novel and innovative scientific discoveries for the benefit of kidney disease patients.
​
These awards will enable researchers to address key scientific and technical questions in kidney-related research, supporting projects with a clearly defined pathway to new therapies, devices, and diagnostics.
​
Guided by unmet clinical needs, these projects will strive to deliver new and more effective solutions to help prevent, protect and treat patients with kidney disease, through the development and testing of new therapies, devices, and diagnostics.
​
-
There are 3 levels of award
-
Up to £120K per project (the award covers 100% of eligible costs)
-
Typically will be provided over the course of 12 months
More information here.
​Quarterly Research Grant Funding Programme
Funder: Cure Parkinson's
Open:
Closes: 3 November 2025
Sector: Healthcare
This scheme is providing grants for scientists and clinicians from universities, hospitals and commercial organisations to help them fund preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.
​
There are grants of up to £250,000 which prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, CP funds clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact CP ahead of submission if you are thinking of applying for a clinical trial.
​
2025/2026 application deadlines:
-
Monday 3 November 2025
-
Monday 12 January 2026
-
Monday 13 April 2026
-
Monday 22 June 2026
-
Monday 12 October 2026
More information here.
​Novel Technology for Intervening in Non-Compressible Haemorrhage
Funder: DASA
Opened: 16 September 2025
Closes: 12pm, 4 November 2025
Sector: Healthcare & Life Sciences
DASA are seeking proposals for novel innovations that intervene to stop non-compressible bleeding. This competition is being run on behalf of Defence Medical Services (DMS) and UK Research & Innovation (UKRI).
​
This competition is seeking novel interventions starting at Technology Readiness Level (TRL) 2-4, for NCH for use prehospital in both combat and civilian settings. DASA expects funded products to progress by one or more TRLs by project end.
​
The total possible funding available for this Themed Competition is £1.5 million. Several proposals may be funded. DASA welcomes submissions from academia, public sector research establishments and the private sector. Projects will last up to three years, with an expected start date of April 2026.
​
DASA are looking for engineering technology-driven, design-led solutions aimed at device-enabled control of haemorrhage. DASA encourage solutions that exploit and integrate existing technologies or approaches used or developed in non-healthcare sectors that could be re-oriented for the NCH challenge.
More information here.​​
Research for Patient Benefit - July 2025
Funder: NIHR
Opened: 16 July 2025
Closes: 1pm, 5 November 2025
Sector: Healthcare & Life Sciences
The NIHR Research for Patient Benefit (RfPB) Programme is inviting outline applications for research proposals that are concerned with the day-to-day practice of health service staff, and that have the potential to have an impact on the health or wellbeing of patients and users of the NHS.
As a researcher-led programme, RfPB does not specify topics for research but instead encourages proposals for projects that address a wide range of health service issues and challenges.
The programme aims to fund high quality quantitative and qualitative research with a clear trajectory to patient benefit. It particularly encourages applications that have a strong element of interaction with patients and the public and that have been conceived in association with a relevant group of service users.
This is a two-stage, commissioned funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.
More information here.
Future Leaders Fellowships: Round 10, business and non-academic
Funder: UK Research and Innovation
Opened: 23 June 2025
Closes: 11am, 5 November 2025
Sector: ALL
Previously funded project’s grant requests have been between £100,000 and £3 million. The maximum grant funding request is £3 million, any requests exceeding this will be classed as ineligible and will not proceed to assessment.
The aim of this competition is to:
-
support ambitious research and innovation to tackle difficult and novel challenges
-
support excellence in innovation, across interdisciplinary boundaries and sectors
-
develop, retain, and attract the next wave of research and innovation leaders
Working with a host organisation a Future Leaders Fellow will receive at least four years of funding to pursue an ambitious programme of innovation. The fellow will also have access to tailored opportunities and resources to develop their career as a future leader in their field.
​
Your project must:
-
deliver research or innovation above and beyond the standard activities of the organisation
-
maximise the impact and influence of the proposed work
-
include a clear programme of skills development, allowing you to fully develop your leadership potential through, for example, mentoring and professional development training
-
have the full support of your host organisation
Your project can:
-
be made up of a single programme of work, or multiple consecutive or concurrent projects led by the Fellow, known as a ‘Portfolio Fellowship’
-
be altered once underway to react to changes in the research landscape or react to business needs
More information here.
Innovation Seed Fund
Funder: RNID
Open
Closes: 5pm, 6 November 2025
Sector: Healthcare
This Fund aims to support innovative research into the causes, treatment and diagnosis of hearing loss, tinnitus and other hearing-related conditions.
​
Value: up to £10,000
Duration: usually up to 1 year
Eligibility: Researchers can be based at a university, research institute or SME anywhere in the world.
​
The scheme will also support small-scale translational research projects, such as proof-of-concept studies or pre-clinical validation studies, with the aim of making novel approaches more competitive for further funding. Development of drugs, diagnostics and devices are welcomed.
More information here.
ITEA Call 2025
Funder: ITEA
Opened: 16 September 2025
Closes: 4pm, 10 November 2025
Sector: ALL
​This call aims to foster software innovation and digital transition by supporting international collaborative R&D projects. Projects can relate to technologies including, but not limited to, artificial intelligence, large language models, process automation and Internet of Things.
​
UK applicants can apply for total grant of up to £750,000 for each project partner.
• All types of UK registered organisations can apply for funding.
• Expected duration 12 – 36 months
• Your project must be collaborative.
​
Mental Health Award: Transforming early intervention for anxiety, depression and psychosis in young people
Funder: Wellcome
Opened: 28 July 2025
Closes: 11 November 2025
Sector: Healthcare
​£200,000 for the Foundation Phase and £5 to £8 million for the Impact Phase.
​
This first phase of the funding call will provide teams with £200,000 to build their teams and develop their detailed proposal for their research study over 12 months. This research proposal must be for a definitive effectiveness study and assessment of strategies for implementation and scaling of a psychological and/or a social intervention. The proposal must capture multiple outcomes that are relevant to people with lived experience and implementing partners, including mental health outcomes, functional outcomes and full economic evaluation.
Projects will be chosen for the Foundation Phase based on:
-
the existing evidence of efficacy for the intervention
-
potential for being taken to scale, with the cost of the intervention low enough to be sustainable in the proposed context
-
potential for sustainable partnerships between research teams and implementing partners
-
outline plans for real-world testing of the effectiveness and implementation of the intervention
Teams taking part in the Foundation Phase will be invited to be part of a learning network to participate and share learning in key areas relevant to developing, implementing and scaling psychological and/or social interventions. Wellcome will work closely with teams during this Foundation Phase as they develop their full research proposals.
More information here.
​Gap fund for early-stage development of new healthcare interventions
Funder: MRC
Opened: 10 July 2025
Closes: 4pm, 12 November 2025
Sector: Healthcare & Life Sciences
Apply for funding to generate critical data that builds confidence in developing a new or repurposed medicine, medical device, diagnostic test, or other medical intervention. Award: £50,000 - £300,000
​
The concept for the product should be backed by prior funding. Projects should focus on one high-risk step, not multiple, to ensure efficient management. This step must address the crucial missing evidence needed to rapidly de-risk onward development or determine failure.
To apply you must be based at a research organisation eligible for MRC funding.
The Gap Fund bridges the smaller Impact Acceleration Account (IAA) and the larger Developmental Pathway Funding Scheme (DPFS).
​
Scope: You can apply for academically led translational projects that aim to undertake a single-step package of work that will bridge the gap between the inception of a new idea and substantive funding through schemes such as the DPFS to:
-
help prevent disease
-
help improve speed and accuracy of diagnosis of disease
-
develop new treatments for disease
-
help to improve outcome monitoring of patients receiving treatment
-
help to improve the management of diseases and conditions
All human diseases and medical interventions are eligible for support, both in the context of UK healthcare and addressing global health issues.
More information here.
Healthcare Innovation Fund
Funder: British Heart Foundation
Opened: 22 September 2025
Closes: 12pm, 17 November 2025
Sector: Healthcare
The lead applicant or investigator must be employed by an NHS organisation or UK academic institution. While a maximum of £350K funding is available, applicants requesting most, or all, of the full amount will need to provide strong reasons to justify the need.
​
Applications are invited from teams who have been identified and supported by UK’s regional innovation boards, like:
-
Health Innovation Networks (HINs) in England
-
Innovation Hubs in Scotland
-
Cardiac Network Board in Wales
-
Cardiology Network in Northern Ireland.
Your project can include working with other partners, such as the third sector and industry, where you think it will benefit people with cardiovascular disease.
It's important that your project considers patient involvement at all levels, from scoping to steering groups.
More information here.
Obesity Pathway Innovation Programme (OPIP): Strands 1, 2 and 3
Funder: Innovate UK
Opened: 8 September 2025
Closes: 19 November 2025
Sector: Healthcare
Innovate UK will work with the Department of Science, Innovation and Technology in partnership with Lilly to invest a total of up to £85 million in innovation projects.
DSIT is providing up to £50 million and Lilly is providing up to £35 million. This includes a minimum of £10 million to be ring fenced for devolved administration health services.
​
Up to £14 million has been allocated to fund innovation projects in this strand of the competition. Funding will be in the form of a grant.Your total eligible project costs will be 100% funded. Total eligible project costs detailed within your application must not exceed the maximum project size. If your total eligible project costs do exceed the maximum then your application will be made ineligible.
​
The aim of this competition is for projects to have developed innovative community and primary care based weight management pathways. The pathways developed will have plausible plans to recruit significant numbers of patients in each year of the project to provide holistic person centred care that is clinically appropriate, effective and resource efficient. Pathways across the UK must offer a range of support for patients, including nationally and locally available lifestyle and weight management interventions, and for those meeting clinical eligibility criteria, access to obesity medications. The pathways are expected to provide patients with access to essential behaviour change support, focusing on nutrition and physical activity, and where appropriate, psychological support to ensure overall wellbeing.
​
To lead a project your organisation:
-
must be an eligible NHS organisation able to receive grant funding with no subsidy. Eligible NHS organisations must have a strategic responsibility for commissioning care, for example - ICBs in England.
-
England: only Integrated Care Boards
-
will be expected to lead a consortium of providers that once procured or commissioned will be able to provide the services outlined in your application
-
must indicate preferred or suggested delivery partners, including intended subcontractors, that can include commercial providers, NHS organisations, community pharmacies, general practices, community interest companies (CICs) or third sector organisations
More information on strand 1 here.
More information on strand 2 here.
More information on strand 3 here.
Discovery Awards
Funder: Wellcome
Open
Closes: 3pm, 25 November 2025
Sector: Healthcare
This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing. Maximum grant of £5m over a maximum duration of 8 years.
​
The lead organisation must be a not-for-profit and can be a:
-
higher education institution
-
research institute
-
healthcare organisation
-
charity or social enterprise
​
Your research must:
-
fit within what Wellcome support in Discovery Research
-
have the potential to improve human life, health, and wellbeing.
Your research can:
-
be in any discipline - including science, technology, engineering and mathematics (STEM), experimental medicine, humanities and social science, clinical/allied health sciences, and public health
-
be in a single discipline or multidisciplinary.
Your research must not:
-
fall outside of what Wellcome support in Discovery Research. Check what Wellcome don't fund.
-
start earlier than seven months after the application deadline.
​
More information here.
​Return to standing after a fall
Funder: NIHR - HTA
Opened: 31 July 2025
Closes: 1pm, 26 November 2025
Sector: Healthcare
This is a 2-stage, commissioned funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.
​
Eligibility - See the HTA Programme page for details about the overall programme remit and eligibility criteria.
​
Research question - What is the clinical and cost effectiveness of an intervention that focuses on training people to return to standing after a fall, compared with usual care, in those at risk of a long-lie?
​
Patient/target group: Older adults living in their own homes, who have recently had a fall and were unable to rise from the floor (return to standing) without the assistance of another person.
​
A randomised controlled trial with an internal pilot phase to test key trial processes such as recruitment and adherence. Clear stop/go criteria should be provided to inform progression from pilot to full trial. Applicants should consider the extent to which ambulance services are involved in referral to (or potential initial delivery of) the intervention. Applicants should consider and describe how the study would take into account the delivery of any concomitant care concerned with falls assessment or prevention. Applicants should also consider how the intervention would work in conjunction with existing service provision, such as falls clinics and reablement services. Consideration should be given to incorporating a process evaluation and qualitative work into the study, for example to gather information about intervention acceptability to service users and professionals, and to inform potential implementation. Minimum duration of follow-up: 12 months.
More information here.
Accelerator Programme
Funder: The Alzheimer Society
Opened: 6 October 2025
Closes: 28 November 2025
Sector: Healthcare
This programme will provide funding (up to £100,000) and support for early stage businesses solving problems in the dementia space. The programme is seeking both digital and physical solutions that solve challenges faced across the dementia pathway, from early diagnosis to end-of-life care.
​
To be eligible you need to:
-
have a registered business in the UK
-
have an innovation that is being developed and/or deployed in the UK
-
have a detailed business plan
-
have a prototype at TRL 6/7
-
be aware that the Funder will look for a return on the investment provided.
More information here.
Innovation Grant
Funder: University Hospitals Birmingham Charity
If you are a member of staff at University Hospitals Birmingham NHS Foundation Trust and you are interested in applying for funding from the hospital charity to benefit your patients then please contact the Grants team on 0121 371 4852 or email charities@uhb.nhs.uk. They will only consider new grant applications.
Closes: 30 November 2025
Sector: Healthcare
​SME Market Expansion Open Call 2026
Funder: EIT Urban Mobility
Opened: 01 October 2025
Closes: 01 December 2025
Sector: Various
The Call is designed to promote business growth and market expansion, encouraging the replication and scaling of successful solutions in new regions or sectors. It offers a strategic platform for SMEs with ambitions to scale by opening subsidiaries or expanding into new markets.
​
The SME Market Expansion Open Call 2026 focuses on accelerating the market uptake of impactful innovations by reducing the risk of development and deployment. EIT Urban Mobility aims to support solutions with a clear path to market, helping cities and businesses confidently procure and scale proven innovations. Through collaboration with an end-client, SMEs can validate their offering in a real-world setting, while gaining visibility and credibility in the European market.
​
The Call will focus on five topics:
-
Public Transport
-
Urban Logistics
-
Electrification of transport and alternative fuels
-
Mobility data management
-
Health and mobility
​
The total estimated funding allocated to this Call is €600,000.
Around 10 projects are to be implemented by 10 different SMEs. Each entity awardee will receive EIT funding allocation of €60,000. This Call is a mono-beneficiary call addressed to small and medium enterprises (SMEs) that are supported by an end client, a public or private entity, committed to testing and demonstrating the solution.
More information here.
6th REINFORCING Open Call
Funder: EC-REINFORCING
Open
Closes: 4pm, 02 December 2025
Sector: ALL
​Project proposals submitted under this call must revolve around practices of Responsible Innovation. Projects should consist of activities including, but not limited to, designing and/or implementing co-creation processes with citizens at large (or specific categories of citizens, e.g. patients) to develop innovative products, processes, and services for grand societal challenges and missions.
Maximum funding is €60,000 per successful applicant.
​
​On October 10th from 10:30 to 12:00 CET, REINFORCING will host a webinar to present call’s details and guide applicants through the application process. To join the webinar, register here.
​
Post-acute infection syndromes, including long COVID and myalgic encephalomyelitis/chronic fatigue syndrome
Funder: NIHR
Opened: 9 July 2025
Closes: 1pm, 2 December 2025
Sector: Healthcare & Life SCiences
​The Efficacy and Mechanism Evaluation (EME) Programme is accepting full applications for research looking into the treatment and management of post-acute infection syndromes and associated conditions, including long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). All proposals submitted must fall within the scope of the EME Programme.
​
​NIHR recognises that developing an application for a phase 2 platform represents a complex bid, which will require time and the navigation of specific challenges. The programme is therefore inviting applications for work which will accelerate the necessary learning and preparation to explore the feasibility of a repurposing platform. This will take the form of an Application Development Award (ADA). It is anticipated that teams may require up to £200,000 of ADA funding over a maximum of 18 months.
​
Applications to this funding opportunity must aim to accelerate the development of an application for a phase 2 platform study to evaluate repurposed pharmaceutical interventions and/or non-pharmaceutical interventions including digital/devices, for the management and treatment of post-acute infections and associated conditions.
More information here.
i4i Product Development Awards
Funder: NIHR
Opened: 8 October 2025
Closes: 1pm, 3 December 2025
Sector: Healthcare & Life Sciences
This is a two-stage funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.
​
i4i PDA is participating in the following funding opportunities with separate applications on the awards management system. Applicants should read each one carefully before applying to the relevant one.
-
i4i PDA commissioned – NIHR James Lind Alliance (JLA) rolling funding opportunity (2025/406)
-
i4i PDA commissioned – NIHR NICE rolling funding opportunity (2025/407)
​
The Product Development Awards (PDA) support collaborative projects and aims to de-risk innovations, supporting early product development and real-world evaluation, to make them more attractive for follow-on funding or commercial investment.
-
Scope: Preclinical and clinical product development and development of real world evidence for NHS or social care adoption. Research proposals must address an area of unmet need and show a clear pathway towards adoption and commercialisation for the proposed innovation.
-
Entry point: Experimental proof-of-concept or laboratory-validated technology; innovations focusing on real-world evidence generation must have regulatory approval or demonstrated equivalent safety and efficacy for the intended use.
-
Exit point: Depending on the entry point, laboratory and/or clinically validated technology or performance of technologies evaluated in a real-world setting.
-
Lead applicant eligibility: HEI, SME, NHS or social care provider, not-for-profit organisation, based in the UK.
-
Minimum number of co-applicants: 2.
-
Funding level: No maximum, NIHR is encouraging ambitious projects with the potential to make a real impact.
-
Project duration: Between 24 – 36 months.
​
Scope
The aim of the PDA is to achieve benefits to patients and end users, de-risk technologies and make them attractive to follow-on funders, investors and buyers, in particular NHS commissioners and national guidance bodies.
Types of project:
-
Product development required to enable technologies for clinical use or use in social care.
-
Clinical development of a laboratory-validated technology.
-
Real-world evaluations to accelerate the development and uptake of innovative products, which already have demonstrated safety and efficacy.
Proposals must:
-
Include a strong element of patient and public involvement, as well as end-user engagement.
-
Set out a commercial strategy that takes into account the regulatory pathway, IP management, commercial barriers, health economics and route to market.
-
Present a plan for future adoption of the technology into the NHS or social care system.
More information here.
Commercial practices and gambling
Funder: NIHR
Opened: 15 July 2025
Closes: 1pm, 9 December 2025
Sector: Healthcare
NIHR's Public Health Research (PHR) Programme is looking to fund research which evaluates the impacts of the commercial practices associated with gambling on health and health inequalities.
​
This is a 2-stage funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.
​
Research question: What are the impacts of the commercial practices associated with gambling on health and health inequalities?
​
Funding opportunity scope:
-
Interventions aimed at preventing or reducing the impact of commercial determinants
-
Gambling industry practices as the intervention
​
Evaluations should aim to develop understanding on the complex interactions between the availability and uptake of gambling activities and the related harms to health. Interventions should be carefully evaluated for both intended and unintended consequences.
More information here.
Research Programme for Social Care (RPSC)
Funder: NIHR
Opened: 3 September 2025
Closes: 1pm, 10 December 2025
Sector: Social Care
This scheme funds research that generates evidence to increase the effectiveness of social care services, provides value for money and benefits people who need or use social care services, and carers.
​
RPSC welcomes high-quality proposals that are focused on but not limited to:
-
Primary, secondary and evidence synthesis research, including qualitative, quantitative and mixed methods designs
-
Studies of social care needs, circumstances and relevant outcomes related to adults, children or young people who need or use social care and carers, including studies of inequalities in any of these domains
-
Evaluation of existing or new social care services, addressing their effectiveness, cost-effectiveness and distributional consequences
-
Effectiveness and cost-effectiveness evaluations of interventions, including adaptations or refinements of existing interventions/technologies
-
Feasibility, pilot and definitive trials
-
Research examining consequences for social care users of provision of other services (e.g., health, education, criminal justice, family courts, housing, benefits)
-
Studies that involve secondary data analysis or record linkage
-
Systematic or other reviews of evidence
-
Research on approaches to support and strengthen the social care workforce.
More information here.
Public Health Research Programme Rapid Funding Scheme
Funder: NIHR
Open
Closes: 27 December 2025
Sector: Healthcare
The Public Health Research (PHR) Programme funds research to generate evidence to inform the delivery of non-NHS interventions, intended to improve the health of the public, and reduce inequalities in health.
​
Proposals submitted to the RFS will
-
make a convincing case of the urgency to undertake the research and justify why the data collection needs to start within a timescale which can’t be accommodated by the programme’s normal research commissioning processes, taking advantage of an unanticipated, time limited, natural experiment opportunity
-
be clear why the work could not have been proposed earlier
-
meet the remit of the PHR programme, with a view to generate evidence to inform the delivery of non-NHS interventions
-
lead to the submission of a proposal for a full evaluation, which would generate research findings that are generalisable and have clear utility for public health decision makers with the potential to change practice
-
be deliverable for a total cost £50,000 or less
-
be for a duration of six months or less
-
be for base line data collection or urgent feasibility work
-
have a study team established and ready to start work if the application is successful
More information here.
NIHR/NICE rolling funding opportunity (HTA Programme)
Funder: NIHR
Opened: 4 September 2025
Closes: 1pm, 7 January 2026
Sector: Healthcare & Life Sciences
The Health Technology Assessment Programme (HTA) is inviting outline applications via the commissioned workstream. We are interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated in the last 5 years.
Applications must be within the remit of the HTA Programme, and the primary outcome measure must be health related. The following research programmes are also participating in this funding opportunity:
After checking the programme remit, you should apply directly to the relevant programme funding opportunity.
This is a 2-stage funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.
More information here.
​Quarterly Research Grant Funding Programme
Funder: Cure Parkinson's
Open:
Closes: 12 January 2026
Sector: Healthcare
This scheme is providing grants for scientists and clinicians from universities, hospitals and commercial organisations to help them fund preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.
​
There are grants of up to £250,000 which prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, CP funds clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact CP ahead of submission if you are thinking of applying for a clinical trial.
​
2025/2026 application deadlines:
-
Monday 3 November 2025
-
Monday 12 January 2026
-
Monday 13 April 2026
-
Monday 22 June 2026
-
Monday 12 October 2026
More information here.
Early action and prevention within Health and Social Care Services
Funder: NIHR
Opened: 26 September 2025
Closes: 1pm, 21 January 2026
Sector: Healthcare, Social Care
The Health and Social Care Delivery Research (HSDR) Programme is looking to fund high quality research about early action and prevention within Health and Social Care Services. This is a 2-stage, commissioned funding opportunity. To apply for the first stage you should submit an outline application. There are no specific eligibility requirements or restrictions for applicants to this funding opportunity.
​
Although not an exhaustive list, some examples of interest for evaluative research are:
-
the pathway, flow, and coordination of patients through prevention services and the broader configuration of prevention services for those with long-term conditions and rehabilitation following acute care
-
innovative ways of providing, commissioning, or streamlining prevention services, for example:
-
the integration of preventative approaches and initiatives within health and social care services (such as original/novel research on NHS vaccination programmes, social prescribing, smoking cessation, preventative clinics/hubs in hospital and primary care settings)
-
the effectiveness of service delivery models enabled by emerging technologies and the trade-off between administrative efficiency and patient/staff experiences
-
-
how data can be used to proactively offer preventative support and how data can be linked across health, social care, and other systems
-
models of effective systems leadership and funding mechanisms to embed prevention into the commissioning and provision of health and social care.
We are looking to fund research which has the potential to inform prevention services at a national level, and therefore local or regional evaluations are unlikely to be fundable.
More information here.
James Lind Alliance Priority Setting Partnerships rolling funding opportunity
Funder: NIHR
Opened: 1pm, 14 October 2025
Closes: 1pm, 28 January 2026
Sector: Healthcare & Life Sciences
​The JLA Priority Setting Partnerships facilitate patients, carers and clinicians to work collaboratively to identify research priorities in particular areas of health and care.
​
Write a maximum of 5 A4 pages for your research plan. When reviewing applications, NIHR will not consider any additional information over this 5 page limit.
Applicants should clearly state how their proposed research addresses a current evidence gap and how the research adds value to the existing NIHR research portfolio.
​
The top 10 priorities (for multiple years and countries) of the JLA priority setting partnerships are shown here. 2025 priorities include:
-
Bone marrow transplantation in paediatrics
-
Burn injury
-
Co-existing dementia and hearing conditions
-
Diverticular disease
-
East London Pandemic PSP for Ethnic Minority Communities
-
Epidermolysis Bullosa
-
Faecal Incontinence in Adults
-
Mental Health and the Body Clock
-
Midwifery Practice and Maternity Care
-
Palliative and End of Life Care Refresh
-
Perianal Crohn’s Disease
-
Prehabilitation for Hip & Knee Replacement Surgery
-
Premature Babies born <25 weeks' gestation
More information here.​​​
​MRC Centre of Research Excellence: round four: outline application
Funders: MRC and MoD
Opened: 1 October 2025
Closes: 4pm, 4th February 2026
Sector:
Total fund: £50,000,000
Maximum award: £26,250,000
​
Apply for MRC Centre of Research Excellence (MRC CoRE) funding to tackle complex and interdisciplinary health challenges. You must be based at a UK research organisation eligible for Medical Research Council (MRC) funding.
​
MRC CoREs will be funded for up to 14 years. Your award will initially last for seven years, with a further seven years based on successful review. The full economic cost (FEC) of your MRC CoRE can be up to £26.25 million for the first seven years.
MRC will fund 80% of the FEC. The maximum MRC contribution will be £21 million.
This is an annual funding opportunity. MRC expects to fund one or two MRC CoREs every year.
​
MRC CoRE challenges are expected to:
-
be bold, ambitious, and innovative, and address a gap or opportunity which is not being adequately addressed elsewhere
-
address substantial unmet needs in understanding or modifying human health and disease
-
be specific, with major strategic objectives achievable within the 14-year timeframe which, if achieved, will transform the research field or area of health research
-
align to the MRC mission
-
require coordinated and flexible, major long-term funding
More information here.
Local Innovation Partnerships Fund
Funder: UKRI
Opened: 6 October 2025
Closes: 4pm, 12 February 2026
Sector: ALL
This programme earmarks at least £20 million for each of ten regions across the UK, including one in each of the devolved nations. The intention is to attract a further £1 billion additional investment, including from the private sector, and £700 million of additional value to local economies. The maximum duration of this award is for five years.
Partnership and co-creation are at the heart of the Local Innovation Partnership Fund. It is open to collaborative proposals co-created between UKRI and locally led triple-helix partnerships/consortia of civic authorities, industry and research organisations.
​
This is a closed funding opportunity, for applications from the places selected by the UK government:
-
Greater Manchester
-
West Midlands
-
South Yorkshire
-
West Yorkshire
-
Liverpool City Region
-
North East England
-
Greater London
-
Cardiff Capital Region
-
Glasgow City Region
-
an innovation corridor spanning Belfast and Derry/Londonderry
​
This will not run as a typical UKRI funding opportunity. Partnership and co-creation are at the heart of the Local Innovation Partnership Fund. It is open to collaborative proposals co-created between UKRI and locally led triple-helix partnerships/ consortia of civic authorities, industry and research organisations.
​
The programme is designed to support places that have an identifiable innovation ecosystem, with high-potential innovation clusters aligned to national policy priorities.
​
Proposals must build on local innovation strengths and opportunities giving places a strong role in determining their priorities, with UKRI providing a national perspective, technical expertise and support.
​
To apply on behalf of your triple helix partnership you must be based at an eligible organisation as follows:
-
higher education providers
-
research institutes
-
public sector research establishments
-
NHS bodies
-
independent research organisations
-
a Mayoral Strategic Authority, or other local government partner that has been granted non-standard eligibility for this funding opportunity
​
The primary objectives of the LIPF are to:
-
foster the growth of mature innovation clusters by deepening their capabilities and expanding their reach
-
support emerging clusters, to grow and mature their ecosystems enhancing their capability of generating substantial economic value
-
support the adoption, diffusion, and commercialisation of new technologies
-
strengthen local partnerships and governance to deliver place-based innovation
​
A competition will run for all other parts of the UK to bid for support to grow their innovation ecosystems. UK Research and Innovation (UKRI) will work with regional partnerships between civic authorities, businesses and research organisations to co-create a portfolio of investment in each region.
More information here.
Work and Health Research Awards Round 2
Funder: NIHR
Opened: 12 June 2025
Closes: 1pm, 11 March 2026
Sector: Healthcare & Life Sciences
The National Institute for Health and Care Research (NIHR) invites applications for work and health research awards. The purpose of these awards is to enable research teams to receive funding for larger programmes of research or large scale and ambitious projects to tackle priorities in work and health research. These awards can cost up to £2 million over 3 years.
This competition aims to:
-
bring together teams representing different disciplines, professions and sectors to submit plans for ambitious research and to catalyse future research capacity;
-
fund large scale, ambitious and transdisciplinary projects or programmes of research addressing key priorities and substantial areas of need in work and health and occupational health.
More information here.
Early Detection and Diagnosis Primer Award
Funder: Cancer Research UK
Open:
Closes: 26 March 2026
This scheme aims to support new and pioneering research ideas and pilot studies of high scientific risk to stimulate and develop the early detection field. Funding is for up to £100,000 for projects lasting up to 1 year led by a scientist, clinician or healthcare worker based in a UK university, medical school, hospital or research institution.
More information here.
Sector: Healthcare & Life Sciences
​Quarterly Research Grant Funding Programme
Funder: Cure Parkinson's
Open:
Closes: 13 April 2026
Sector: Healthcare
This scheme is providing grants for scientists and clinicians from universities, hospitals and commercial organisations to help them fund preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.
​
There are grants of up to £250,000 which prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, CP funds clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact CP ahead of submission if you are thinking of applying for a clinical trial.
​
2025/2026 application deadlines:
-
Monday 3 November 2025
-
Monday 12 January 2026
-
Monday 13 April 2026
-
Monday 22 June 2026
-
Monday 12 October 2026
More information here.
Experimental medicine stage one
Funder: MRC
Opened: 2 October 2025
Closes: 4pm, 15 April 2026
Sector: Life Sciences
Apply for funding to investigate the causes, progression and treatment of human disease.
Your project must:
-
focus on a mechanistic hypothesis
-
include an experimental intervention or challenge in humans
You must be a researcher based at a research organisation eligible to apply for MRC funding. If you are taking the next step towards becoming an independent researcher, you may be eligible to apply as a ‘new investigator.
​
There is no limit to the amount of funding you can apply for (Total fund is £10m) or the length of your project. The MRC will fund 80% of your project’s full economic cost.
​
This is an ongoing funding opportunity. Application rounds close every April and October.
More information here.
Veterans' health
Funder: NIHR
Opened: 15 July 2025
Closes: 1pm, 21 April 2026
Sector: Healthcare & Life Sciences
This scheme aims to support research which evaluates the effects of interventions on the mental, physical, or both aspects of Veterans' health.
NIHR is seeking research that evaluates interventions which can have an impact on the mental and physical health outcomes of veterans through community-based public health approaches. This can include both targeted, small-scale initiatives and larger community-level strategies that enhance access to health and well-being services for veterans, as well as other policy decisions in areas outside of health that may impact health. NIHR is particularly interested in interventions that address key barriers to healthcare access, promote early intervention, and support veterans' transition to civilian life.
Evaluations should clearly define the nature of the intervention from the outset, avoiding broad generalisations and ensuring a precise understanding of the mechanisms at play.
More information here.
Men’s mental health
Funder: NIHR
Opened: 15 July 2025
Closes: 1pm, 21 April 2026
Sector: Healthcare
​​NIHR's Public Health Research (PHR) Programme is looking to fund research which evaluates the health and health inequality impacts of interventions aimed at promoting good mental health or preventing poor mental health among men.
This is a 2-stage funding opportunity. To apply for the first stage you should submit an outline application. If invited to the second stage, you will then need to complete a full application.
​
Research question: What are the health and health inequality impacts of interventions aimed at promoting good mental health or preventing poor mental health among men?
​
This funding opportunity focuses on research evaluating mental health interventions (excluding individual-level mental health treatments) for men at different stages of the life-course. NIHR's Public Health Research (PHR) Programme prioritises interventions at a population or group level, rather than individual interventions, with a focus on addressing health inequalities and the wider determinants of health.
​
Suggested research areas include, but are not limited to, evaluations of:
-
interventions that utilise lifestyle behaviours or changes to improve men’s mental health
-
community-based interventions
-
programmes adopting a whole-community approach to men’s mental health. This could include interventions:
-
based in specific settings, such as schools, colleges, universities, workplaces, leisure venues, places of worship, community groups and services, health centres, or criminal justice settings
-
focused on specific population groups, such as men from particular ethnic minority groups, men from sexual and gender minorities, or men experiencing different forms of disadvantage
-
for which the primary focus of the intervention is not necessarily on improving mental health, but the activity or mechanism might impact mental health (positively or negatively)
-
interventions that address the multiple, interacting disadvantages affecting the most marginalised men
-
trauma-informed and trauma-specific interventions
-
interventions or initiatives aimed at proactively addressing help seeking behaviour among men at risk of perpetrating violence and their impact on mental health
-
interventions related to the influence of societal and cultural norms, gender roles and beliefs across diverse male populations
-
evaluation of public health campaigns and educational initiatives designed to challenge harmful gender stereotypes and to support healthy relationships
-
intergenerational interventions
-
Interventions that take a holistic, person-centred approach
-
peer support interventions
-
interventions related to social media, or online images, messages, or digital content
-
the impact of drugs and alcohol
More information here.
​Quarterly Research Grant Funding Programme
Funder: Cure Parkinson's
Open:
Closes: 22 June 2026
Sector: Healthcare
This scheme is providing grants for scientists and clinicians from universities, hospitals and commercial organisations to help them fund preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.
​
There are grants of up to £250,000 which prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, CP funds clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact CP ahead of submission if you are thinking of applying for a clinical trial.
​
2025/2026 application deadlines:
-
Monday 3 November 2025
-
Monday 12 January 2026
-
Monday 13 April 2026
-
Monday 22 June 2026
-
Monday 12 October 2026
More information here.
​Quarterly Research Grant Funding Programme
Funder: Cure Parkinson's
Open:
Closes: 12 October 2026
Sector: Healthcare
This scheme is providing grants for scientists and clinicians from universities, hospitals and commercial organisations to help them fund preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s.
​
There are grants of up to £250,000 which prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, CP funds clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact CP ahead of submission if you are thinking of applying for a clinical trial.
​
2025/2026 application deadlines:
-
Monday 3 November 2025
-
Monday 12 January 2026
-
Monday 13 April 2026
-
Monday 22 June 2026
-
Monday 12 October 2026
More information here.
Impact in Healthcare Fund
Funder: Peter Sowerby Foundation
Ongoing
Sector: Healthcare
Initial discussions with prospective organisations will take place before an invitation to submit a formal application is made. If you believe that you have an idea for a project that is closely aligned with the Foundation's aims and recent grants, please submit a brief synopsis, including a summary budget and proposed timeline, using the form here. The Foundation cannot respond to all the ideas it is sent, but they do read all proposals and get in touch with those they feel could be a good fit.
​
The Foundation is currently seeking to fund projects which:
-
Tackle a clear and demonstrable need* across a range of health condition
AND
-
Are proven to be impactful and where additional funds could EITHER increase the scale or depth of impact OR sustain projects ‘at risk’.
The Foundation will prioritise applications which focus on:
-
outreach and delivery in the community, as opposed to formal healthcare settings OR
-
work with a digital or data focus OR
-
preventative health care to improve patient well-being.
​
The Foundation is seeking projects where:
-
there is clear evidence of the need for a specific health intervention OR
-
there is a gap in the availability of treatment or support OR
-
the quality of support available is not up to a required standard.
Applicants may look to evidence need in different ways. This might include empirical evidence, academic or sector-led research or consultation (for example, with beneficiary groups or health professionals).
​
There are two strands of grants:
​
Grant 1
Grants of up to £500,000, potentially over multiple years - for projects which are (projects must fit all of the below):
-
proven
-
ready to scale
-
run by organisations with compelling track records and an established leadership team.
-
backed by clear evidence of need.
-
sustainable in the long-term following the Foundation’s investment.
​
Grant 2
Substantial Grants ~£2-3million over multiple years.
From time to time, the Foundation will invite organisations to develop projects which are impactful in a specific area of the Foundation’s interest, and which align with the aims and objectives of the Impact in Healthcare Fund.
It is envisaged that funds could be spent in a range of different ways for example:
-
supporting infrastructure OR
-
core staffing posts OR
-
existing impactful initiatives and which could be sustained over a long-term period thanks to funds from the Foundation OR
-
scale-up of pilot activities which show proven impact OR
-
other means suggested by the applicant.
Impact Jersey Innovation Programme
Funder: Impact Jersey
Open
Closes: Ongoing
Sector: Healthcare
Whether you’re developing a pilot, a proof of concept, or a scalable solution, the programme offers:
-
Applications open all year round
-
Flexible funding aligned to Jersey’s strategic priorities
-
1-to-1 support to shape stronger proposals
From application guidelines to funding info and FAQs, everything you need is now live on the application page.
​
Up to £500,000 will be available per quarter (with a maximum of £1 million available in 2025 and £2 million during 2026).
Impact Jersey focuses on funding a range of technology solutions to key issues and addressing strategic priorities defined by the Government of Jersey. To delve deeper into Ministerial Priorities click on pages 6 & 7 of the Impact Jersey Strategic Programme Proposal.
​
Key health ones are:
-
Ageing Population - How can we help people live independently for longer?
-
Health & Wellbeing - How can we monitor and identify hazards to health and provide interventions at the earliest opportunity?
​
Global Innovation Fund- Grants
Funder: Global Innovation Fund
Open, no closing date
Sector: All
The Global Innovation Fund is a non-profit, impact-first investment fund headquartered in London with offices in Washington, D.C. and Nairobi. It invests in the development, rigorous testing, and scaling up of new products, services, business process, or policy reforms that are more cost-effective than current practice and targeted at improving the lives of the world's poorest people.
​
It accepts applications from organisations working in any sector in any developing country. Any type of organisation may apply. This includes social enterprises, for-profit companies, non-profit organisations, government agencies, international organisations, and research institutions in any country. It is recommended that individual innovators, entrepreneurs, or researchers apply through an affiliated organisation.
Big Ideas
Funder: CW+
Open, no closing date
Sector: Healthcare & Life Sciences
If you're an employee of Chelsea and Westminster Hospital NHS Foundation Trust, then you can apply for this grant.
​
The programme is designed to: promote innovation, transformation and new service development; support staff in the delivery of front line patient care. Awards are usually up to £50,000.
More information here.
Pre-Seed Challenge Fund
Funder: Lyva Labs
Ongoing
Sector: Healthcare & Life Sciences
Businesses and start-ups working in the Diagnostics/Med Tech/Health Tech/Digital Health space can apply for funding to support idea development and commercialisation.Innovative businesses and start-ups across the region (Liverpool City) can apply for investment of £25,000 to £250,000 for idea development and commercialisation. Total fund of £6m. Businesses must be based or willing to relocate to Liverpool City Region.
More information here.
Catapult/RTO Grants
Funder: Innovate UK Business Growth
Open, no closing date
Sector: All
Up to £15,000 grants available for:
-
Sector specific advice on expertise;
-
Testing and/or development work;
-
Market analysis, cost modelling etc;
-
Identifying opportunities for R&D, partnership building & collaboration, and more.
More information.​